#Therapy #NHS Risk of Local Recurrence Varies Across Sarcoma Histotypes With Adjuvant/Neoadjuvant Therapy Adjuvant chemotherapy was found to decrease the rates of local recurrence in some subtypes of extremity soft tissue sarcoma; however, the use of adjuvant/neoadjuvant therapy did not impact overall survival, according to findings from a large analysis ... http://www.targetedonc.com/conference/ctos-2016/risk-of-local-recurrence-varies-across-sarcoma-histotypes-with-adjuvan
October 15, 2014 is BRA Day - Breast Reconstruction Awareness Day. An effort to increase awareness for women regarding their options for reconstruction & the best way to go about it when faced with a mastectomy & adjuvant chemotherapy.
Genetic Recurrence Score Predicts Locoregional Risk in Node-Positive, ER-Positive Breast Cancer After Adjuvant Chemotherapy and Tamoxifen - Chemotherapy Advisor
Breast Cancer: Don't Delay Chemo - Delaying adjuvant chemotherapy for #breastcancer more than 60 days significantly increased the odds of premature death and distant metastasis, a review of almost 7,000 cases showed. (via MedPage Today, Published: Jan 27, 2014)
A new study has demonstrated that treatment with adjuvant paclitaxel and trastuzumab (Herceptin, Genentech) is highly effective in patients with stage I, node-negative, HER2-positive breast cancer. Although this finding comes from a Phase II trial, clinicians believe it will have a great influence on practice.